Edgewise Therapeutics
Delaney Shaw has a diverse work experience in the pharmaceutical and biotech industry. Delaney is currently working as a Manager, Clinical Operations at Edgewise Therapeutics since May 2022. Prior to this, Delaney was an Associate Clinical Project Manager at Imara Inc. from October 2021 to May 2022. Delaney also served as a Clinical Trial Manager at Alexion Pharmaceuticals, Inc. from February 2021 to October 2021 and as a Project Manager, Global Medical Affairs from April 2020 to February 2021. Before joining Alexion Pharmaceuticals, Delaney worked as an Associate Project Manager at Parexel from May 2019 to April 2020. Their earlier experience includes working as a Research Associate at NovoBiotic Pharmaceuticals from September 2017 to May 2019.
Delaney Shaw completed their Bachelor's Degree in Microbiology from California Polytechnic State University-San Luis Obispo, spanning from 2013 to 2017. Following that, they pursued a Master of Science degree in Regulatory Affairs and Health Policy from Massachusetts College of Pharmacy and Health Sciences, which they successfully completed between 2019 and 2021.
This person is not in any offices
Edgewise Therapeutics
1 followers
Edgewise Therapeutics is a biotechnology company harnessing proven expertise and understanding of skeletal muscle physiology to develop novel, transformative therapies for serious muscle diseases. Based in Boulder, Colorado, we have built a state-of-the-art muscle research facility to capitalize on new insights into the nature and consequences of muscle adaptation and injury with disease. Edgewise recently closed it’s Series B financing round which will support the advancement of Edgewise Therapeutic’s lead product candidate into clinical development for Duchenne and Becker Muscular Dystrophy (DMD and BMD) as well as expansion of the company’s pipeline. The company’s leadership team has founded multiple biotechnology startups, several of which have gone on to become publicly-traded companies and brings to bear a depth of experience in drug discovery, development and commercialization.